Cardiology News

After years of failed attempts to develop therapies meant to reduce elevated triglycerides, novel agents are now showing promise in the management of hypertriglyceridemia, a speaker said.

BOSTON — Patients struggling to meet cardiometabolic treatment targets may benefit from an assessment of social determinants of health, which could reveal food, housing or financial insecurity issues that play a large role in their health.

NEW ORLEANS — Both new-onset and ongoing untreated hypertension were associated with increased risks for newly diagnosed uterine fibroids among midlife women, according to findings presented at the ASRM Scientific Congress & Expo.

There is growing evidence that elite athletes with genetic heart disease could reasonably return to play after a sudden cardiac arrest, although a shared decision-making process may be appropriate.

BOSTON — In this Healio video exclusive, Anne L. Peters, MD, delineates how the diagnosis of diabetes is heterogeneous and requires clinicians to “individualize our assessment of patients, and therefore our treatment of patients.”

BOSTON — In this Healio video exclusive, Paul M. Ridker, MD, MPH, discusses the use of low-dose colchicine to target inflammation in patients who remain at high CVD risk despite controlled LDL.

BOSTON — After years of failed clinical trials with agents to lower severely elevated triglycerides, emerging therapeutics hold promise for effectively addressing hypertriglyceridemia and reducing associated CV risks, a speaker reported.

BOSTON — Simple steps to optimize poor sleep habits can translate to large gains in cardiometabolic health, including improvements in BP, insulin resistance and even appetite regulation, according to a speaker.

BOSTON — Out-of-office BP measurements provide the clearest picture of CV risk for patients and are the ideal method to diagnose and treat hypertension, yet most clinicians still rely on inaccurate clinic readings, according to a speaker.

BOSTON — Continuous glucose monitoring is becoming a mainstay of care for people with type 1 and type 2 diabetes, yet providers should be cautious about the technology’s application for people without diabetes looking for a “wellness” tool.